289 related articles for article (PubMed ID: 35658548)
1. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition.
Pan Y; Gu Z; Lyu Y; Yang Y; Chung M; Pan X; Cai S
Rejuvenation Res; 2022 Aug; 25(4):160-172. PubMed ID: 35658548
[TBL] [Abstract][Full Text] [Related]
2. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
3. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
[TBL] [Abstract][Full Text] [Related]
4. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka B; Storer M; Mas A; Heinzmann F; Ortells MC; Morton JP; Sansom OJ; Zender L; Keyes WM
Genes Dev; 2017 Jan; 31(2):172-183. PubMed ID: 28143833
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
6. Senescence in head and neck squamous cell carcinoma: relationship between senescence-associated secretory phenotype (SASP) mRNA expression level and clinicopathological features.
Ostrowska K; Niewinski P; Piotrowski I; Ostapowicz J; Koczot S; Suchorska WM; Golusiński P; Masternak MM; Golusiński W
Clin Transl Oncol; 2024 Apr; 26(4):1022-1032. PubMed ID: 38175424
[TBL] [Abstract][Full Text] [Related]
7. Chromatin basis of the senescence-associated secretory phenotype.
Hao X; Wang C; Zhang R
Trends Cell Biol; 2022 Jun; 32(6):513-526. PubMed ID: 35012849
[TBL] [Abstract][Full Text] [Related]
8. Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming.
von Joest M; Chen C; Douché T; Chantrel J; Chiche A; Gianetto QG; Matondo M; Li H
Cell Rep; 2022 Jul; 40(2):111074. PubMed ID: 35830812
[TBL] [Abstract][Full Text] [Related]
9. The senescence-associated secretory phenotype in ovarian cancer dissemination.
Veenstra JP; Bittencourt LFF; Aird KM
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C125-C132. PubMed ID: 35584328
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
[TBL] [Abstract][Full Text] [Related]
11. Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
Okamura K; Sato M; Suzuki T; Nohara K
Toxicol Appl Pharmacol; 2022 Nov; 454():116231. PubMed ID: 36089002
[TBL] [Abstract][Full Text] [Related]
12. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
13. Senescence-associated secretory phenotype and its impact on oral immune homeostasis.
Yue Z; Nie L; Zhao P; Ji N; Liao G; Wang Q
Front Immunol; 2022; 13():1019313. PubMed ID: 36275775
[TBL] [Abstract][Full Text] [Related]
14. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
Lau L; David G
Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
[No Abstract] [Full Text] [Related]
15. Spatial and Temporal Control of Senescence.
Ito Y; Hoare M; Narita M
Trends Cell Biol; 2017 Nov; 27(11):820-832. PubMed ID: 28822679
[TBL] [Abstract][Full Text] [Related]
16. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
17. Aging-related decrease of histone methyltransferase SUV39H1 in adipose-derived stem cells enhanced SASP.
Li R; Teng Y; Guo Y; Ren J; Li R; Luo H; Chen D; Feng Z; Fu Z; Zou X; Wang W; Zhou C
Mech Ageing Dev; 2023 Oct; 215():111868. PubMed ID: 37666472
[TBL] [Abstract][Full Text] [Related]
18. The mechanotransduction of MLO-Y4 cells is disrupted by the senescence-associated secretory phenotype of neighboring cells.
Gardinier JD; Chougule A; Zhang C
J Cell Physiol; 2022 Apr; 237(4):2249-2257. PubMed ID: 35102547
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Communication of the SASP: Dynamic, Interactive, and Adaptive Effects on the Microenvironment.
Giroud J; Bouriez I; Paulus H; Pourtier A; Debacq-Chainiaux F; Pluquet O
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445973
[TBL] [Abstract][Full Text] [Related]
20. Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.
Wang WJ; Cai GY; Chen XM
Oncotarget; 2017 Sep; 8(38):64520-64533. PubMed ID: 28969091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
